Company: BDRX
Filing Date: 2025-01-17
Form Type: F-1
Source: 0001214659-25-000922
Chunk: 216

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-17
Form: F-1
Chunk 216
---
 | 16 |     |      | 22 |     |      | 15 |
| General and administration |     |                    |  5 |     |      |  5 |     |      |  5 |
| Total                      |     |                    | 21 |     |      | 27 |     |      | 20 |

|                     |     | As of December 31, |    |     |      |    |     |      |    |
|                     |     |               2022 |    |     | 2021 |    |     | 2023 |    |
| Geography:          |     |                    |    |     |      |    |     |      |    |
| United Kingdom      |     |                    | 19 |     |      | 25 |     |      | 19 |
| Germany             |     |                    |  1 |     |      |  1 |     |      |  1 |
| Republic of Ireland |     |                    |  1 |     |      |  1 |     |      | -- |
| Total               |     |                    | 21 |     |      | 27 |     |      | 20 |

To our knowledge, none of
our employees are currently represented by labor unions or covered by collective bargaining agreements. We consider our relationship with
our employees to be good.

| 106 |

Historical Background and Corporate Structure

We were originally formed
as a limited liability company under the laws of England and Wales in 2000 under the name Midatech Ltd, which acquired its base nanoparticle
technology through an assignment of worldwide commercialization rights and joint ownership of patent rights from Consejo Superior de Investigaciones
Cientificas, or CSIC, in Madrid, Spain. Midatech Ltd was a research and development focused biotech company which subsequently advanced
and developed this gold nanoparticle drug delivery platform technology to enhance the delivery of medicines for major therapeutic indications
where clinical therapeutic options are limited, with a particular focus on certain cancers, such as liver and brain cancer.

To better be able to continue
the commercial development of the research and development programs of Midatech Ltd, Midatech Pharma PLC was incorporated on September
12, 2014 under the laws of England and Wales, to be the public holding company of Midatech Ltd and Midatech Pharma (Wales) Limited under
registered number 09216368. On December 8